Systemic levels of cytokines and GAD-specific autoantibodies isotypes in Chinese IDDM patients

Diabetes Research and Clinical Practice

Volumn 43, Issue 2, 1999, Pages 127-135

  Ng, W Y ^a   Thai, A C ^a   Lui, K F ^a   Yeo, P P B ^a   Cheah, J S ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cytokines; GADab IgG subclass; IDDM

Indexed keywords

AUTOANTIBODY; CYTOKINE; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE;

ADOLESCENT; ADULT; ANIMALS; AUTOANTIBODIES; CHINA; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; MALE; MICE; REGRESSION ANALYSIS; SINGAPORE; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032918261     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(98)00130-2     Document Type: Article

References (47)

1. Druet P., Sheela R., Pelletier L. Th1 and Th2 cells in autoimmunity. Clin. Exp. Immunol. 101(Suppl. 1):1995;9-12.
2. Romanagani S. Human TH1 and TH2 subsets: doubt no more. Immunol. Today. 12:1991;256-257.
3. Katsikis P.D., Cohen S.B.A., Londel M., Feidmann M. Are CD4+Th1 cells pro-inflammatory or anti-inflammatory? The ratio of IL-10 to IFN-gamma or IL-2 determines their function. Int. Immunol. 7:1995;1287-1294.
4. Daniel D., Gill R.G., Schloot N., Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25:1995;1056-1062.
5. Tisch R., Yang X.-D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:1993;72-75.
6. Kaufmann D.L., Clare-Salzler M., Tian J. et al. Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:1993;69-72.
7. Rabinovitch A. Immunoregulalory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes. 43:1994;613-621.
8. Rabinovitch A., Suarez-Pinzon W., El-Sheikh A., Sorensen O., Power R.F. Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: expression of Th1 cytokines correlates with beta-cell destructive insulitis and IDDM. Diabetes. 45:1996;749-754.
9. Zipris D. Evidence that Th1 lymphocytes predominate in islet inflammation and thyroiditis in the BioBreeding (BB) rat. J. Autoimmunity. 9:1996;315-319.
10. Chang J.C., Linarelli L.G., Laxer J.A. et al. Insulin-secretory-granule specific T cell clones in human IDDM. J. Autoimmunity. 8:1995;221-234.
11. Huang G.C., Tremble J., Bailyes E. et al. HLA-DR restricted T cell lines from newly diagnosed type 1 diabetes patients specific for insulinoma and normal islet beta cell proteins: lack of reactivity to glutamic acid decarboxylase. Clin. Exp. Immunol. 102:1995;152-158.
12. Weiss U., Manfras B.J., Terjung D. et al. In vitro stimulation with glutamic acid decarboxylase (GAD65) leads to an oligonal response to peripheral T-cells in an IDDM patient. Scand. J. Immunol. 42:1995;673-678.
13. Roep B.O. T-cell responses to autoantigens in IDDM. The search for the holy grail. Diabetes. 45:1996;1147-1156.
14. Elliot J.F., Qin H.-Y., Bhatti S. et al. Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune disease in NOD mice. Diabetes. 43:1994;1494-1499.
15. Tian J., Atkinson M.A., Clare-Salzler M. et al. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:1996;1561-1567.
16. Tian J., Clare-Salzler M., Herschenfeld A. et al. Modulating autoimmune response to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat. Med. 2:1996;1348-1353.
17. Ma S.W., Zhao D.-L., Yin Z.-Q. et al. Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nat. Med. 3:1997;793-796.
18. Harrison L.C., Honeyman M.C., De Azipurua H.J. et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet. 341:1993;1365-1369.
19. Ellis T.M., Darrow B., Campbell L., Atkinson M.A. Inverse relationship between humoral and cellular immune responses to glutamate decarboxylase 65 (GAD) and insulin in IDD (Abstract). Diabetes. 44(Suppl. 1):1995;52A.
20. Richter W., Endl J., Eiermann T.H. et al. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Proc. Natl. Acad. Sci. USA. 89:1992;8467-8471.
21. Richter W., Jury K.M., Loeffler D., Manfras B.J., Eiermann T.H., Boehm B.O. Immunoglobulin variable gene analysis of human autoantibodies reveals antigen-driven immune response to glutamate decarboxylase in type I diabetes mellitus. Eur. J. Immunol. 25:1995;1703-1712.
22. Thai A.C., Ng W.Y., Loke K.Y., Lee W.R.W., Lui K.F., Cheah J.S. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM. Diabetologia. 40:1997;1425-1430.
23. Ng W.Y., Thai A.C., Lui K.F., Yeo P.P.B., Cheah J.S. Non-restricted immunoglobulin-G subclass islet cell antibodies in Chinese. Autoimmunity. 15:1993;305-309.
24. Brown W.C., Woods V.M., Chitko-McKown C.G., Hash S.M., Rice-Ficht A.C. Interleukin-10 is expressed by bovine type 1 helper, type 2 helper and unrestricted parasite-specific T-cell clones and inhibits proliferation of all three subsets in an accessory-cell-dependent manner. Infect. Immunity. 62:1994;4697-4708.
25. Espersen G.T., Mathiesen O., Grunnet N., Jensen S., Ditzel J. Cytokine plasma levels and lymphocyte subsets in patients with newly diagnosed insulin-dependent (type 1) diabetes mellitus before and following initial insulin treatment. APMIS. 101:1993;703-706.
26. Nicoletti F., Scalia G., Condorelli F. et al. Anti-cytomegalovirus IgM and IgG antibodies, islet cell antibodies and gamma interferon serum levels in newly diagnosed IDDM patients. Int. J. Immunopath. Pharmacol. 4:1991;99-106.
27. Moordian A.D., Reed R.L., Meredith K.E., Scuderi P. Serum levels of tumor necrosis factor and IL-1 alpha and IL-1 beta in diabetic patients. Diabetes Care. 14:1991;63-65.
28. Cavallo M.G., Pozzilli P., Bird C. et al. Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin. Exp. Immunol. 86:1991;256-259.
29. Hussain M.J., Peakman M., Gallati H. et al. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia. 39:1996;60-69.
30. Ng W.Y., Thai A.C., Lui K.F., Yeo P.P.B., Cheah J.S. Soluble T-cell markers and serum cytokines in type I (insulin-dependent) diabetes mellitus. Int. Arch. Allergy. Immunol. 108:1995;39-42.
31. Luger A., Schernthaner G., Urbanski A., Luger T.A. Cytokine production in patients with newly diagnosed insulin-dependent (type 1) diabetes mellitus. Eur. J. Clin. Invest. 18:1988;233-236.
32. Shah U., Karch L., Baker L., Kier Z.S. Low interleukin-2 synthesis by type 1 diabetics is regulated at the pretranslational level. Clin. Immunol. Immunopathol. 61:1991;177-190.
33. Trinchieri G. Interleukin-12 and its role in the generation of TH1 cells. Immunol. Today. 14:1993;335-338.
34. Scott P. IL-12: initiation cytokine for cell-mediated immunity. Science. 260:1993;496-497.
35. Berman M.A., Sandborg C.I., Wang Z. et al. Decreased IL-4 production in new onset type 1 insulin-dependent diabetes mellitus. J. Immunol. 157:1996;4690-4696.
36. Kallmann B.A., Huther M., Tubes M. et al. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes. 46:1997;237-243.
37. Wilson S.B., Kent S.C., Patton K.T. et al. Extreme Th1 bias of invariant Vα2 4JαQ T cells in type 1 diabetes. Nature. 391:1998;177-181.
38. Petersen J.S., Kulmala P., Knip M., Dyrberg T. GAD65 antibody isotypes in first degree relatives suggest a Th2 immune response in non-progressors (Abstract). Diabetologia. 39(Suppl. 1):1996;A92.
39. Rizzo L.V., de Kruygg R.H., Umetsu D.T., Caspi R.R. Regulation of the interaction between Th1 and Th2 T cell clones to provide help for antibody production in vivo. Eur. J. Immunol. 25:1995;708-716.
40. Snapper C.M., Peschel C., Paul W.E. IFN-γ stimulates IgG 2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol. 140:1988;2121-2127.
41. Lundgren M., Persson U., Larsson P. et al. Interleukin 4 induces synthesis of IgE and IgG 4 in human B cells. Eur. J. Immunol. 19:1989;1311-1315.
42. Flores-Romo L., Millsum M.J., Gillis S., Stubbs P., Sykes C., Gordon J. Immunoglobulin isotype production by cycling human B lymphocytes in response to recombinant cytokines and anti-IgM. Immunology. 69:1990;342-347.
43. Malisan F., Briere F., Bridon J.M. et al. Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes. J. Exp. Med. 183:1996;937-947.
44. Couper J.J., Harrison L.C., Aldis J.J.E., Colman P.G., Honeyman M.C., Ferrante A. IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin dependent diabetes. Hum. Immunol. 59:1998;493-499.
45. Omar M.A.K., Srikanta S., Eisenbarth G.S. Human islet cell antibodies: immunoglobulin class and subclass distribution defined by monoclonal antibodies. Diabetes Res. 4:1987;155-157.
46. Schatz D.A., Barrett D.J., Maclaren N.K., Riley W.J. Polyclonal nature of islet cell antibodies in insulin-dependent diabetes. Autoimmunity. 1:1988;45-50.
47. Millward A., Hussain M.J., Peakman M., Pyke D.A., Leslie D.G., Vergani D. Characterization of islet cell antibody in insulin dependent diabetes: evidence for IgG 1 subclass restriction and polyclonality. Clin. Exp. Immunol. 71:1988;353-356.